Akdeniz diyetinin nemli bir bileeni olan zeytinya, hem ya asidi profili hem de polifenol ieriiyle bu etkiye katkda bulunmaktadr
Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
Consistently, in another in vivo/in vitro study using a rat transient MCAO model, exendin-4 reduced BBB tight-junction protein degradation by inhibiting MMP-9 activation and reactive oxygen species (ROS) production via activation of the Wnt/-catenin signaling pathway [64]
For those interested in learning more about peptide therapies, consider exploring episodes of the Huberman Lab Podcast hosted by Dr